摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,8-bis(trifluoromethyl)quinolin-4-yl 4-methylbenzenesulfonate | 150785-70-9

中文名称
——
中文别名
——
英文名称
2,8-bis(trifluoromethyl)quinolin-4-yl 4-methylbenzenesulfonate
英文别名
4-Methylbenzenesulfonic acid 2,8-bis(trifluoromethyl)-4-quinolyl ester;[2,8-bis(trifluoromethyl)quinolin-4-yl] 4-methylbenzenesulfonate
2,8-bis(trifluoromethyl)quinolin-4-yl 4-methylbenzenesulfonate化学式
CAS
150785-70-9
化学式
C18H11F6NO3S
mdl
——
分子量
435.347
InChiKey
ALIQIEYNTHMVCE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    107 °C
  • 沸点:
    478.1±45.0 °C(Predicted)
  • 密度:
    1.482±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    29
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    64.6
  • 氢给体数:
    0
  • 氢受体数:
    10

SDS

SDS:239a1de38cf70aa56ebf862f2dd826f7
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    2,8-bis(trifluoromethyl)quinolin-4-yl 4-methylbenzenesulfonate磷化氢 作用下, 以 溶剂黄146 为溶剂, 反应 4.0h, 以80%的产率得到4-溴-2,8-二(三氟甲基)喹啉
    参考文献:
    名称:
    喹啉类似物的合成:寻找抗疟药
    摘要:
    已开发出有前途的抗疟药4(3-羟基吡咯烷-1-基)和4(3-羟基哌啶-1-基)-2,8-双(三氟甲基)喹啉的新颖合成途径。
    DOI:
    10.1007/s00706-007-0772-5
  • 作为产物:
    描述:
    邻氨基三氟甲苯 在 sodium hydroxide 作用下, 以 丙酮 为溶剂, 反应 3.0h, 生成 2,8-bis(trifluoromethyl)quinolin-4-yl 4-methylbenzenesulfonate
    参考文献:
    名称:
    Meshram, H. M.; Chennakesava Reddy, B.; Aravind Kumar, D., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2012, vol. 51, # 9, p. 1411 - 1416,6
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Enantioselective synthesis method of 4-aminoalcoholquinoline derivatives and the use
    申请人:Université de Picardie Jules Verne
    公开号:EP2487157A1
    公开(公告)日:2012-08-15
    Mefloquine derivatives, contrary to chloroquine derivatives have not been widely studied to date. Consequently, mefloquine and its derivatives still remain very attractive synthetic targets. Although mefloquine is usually used clinically as a racemic mixture, some studies have shown that its (+)-enantiomer is more potent than the (-)-enantiomer. Moreover, the (-)-enantiomer is responsible for side effects due to reaction with the central nervous system adenosine receptors, while the (+)-enantiomer does no bind at this binding site. Recently, different libraries of racemate 4-aminoalcoholquinolines showed interesting anti-malarial activities. Herein, the present invention describes an enantiopure synthetic and straightforward route to prepare pure enantiomer 4-aminoalcoholquinoline derivatives through the 4-oxirane key-intermediate. A regioselective SN2 ring opening of this epoxide, by diverse amines, allows to obtain the corresponding (R) or (S) 4-aminoquinolines with good yields and enantiomeric excesses generally superior to 92%. The reported methodology appears suitable for the synthesis of a large number of pure enantiomer 4-aminoalcoholquinoline derivatives.
    梅氟喹诺酮衍生物与氯喹诺酮衍生物相比,迄今为止尚未广泛研究。因此,梅氟喹诺酮及其衍生物仍然是非常有吸引力的合成目标。虽然梅氟喹诺酮通常作为外消旋混合物在临床上使用,但一些研究表明其(+)-对映体比(-)-对映体更有效。此外,(-)-对映体由于与中枢神经系统腺苷受体的反应而导致副作用,而(+)-对映体则不会在该结合位点结合。最近,不同的外消旋4-氨基醇喹啉库显示出有趣的抗疟活性。在此,本发明描述了一种对映纯的合成和直接的途径,通过4-环氧丙烷关键中间体制备纯对映体4-氨基醇喹啉衍生物。通过多种胺的区域选择性SN2环开放该环氧化物,可以获得相应的(R)或(S)4-氨基喹啉,并且收率和对映体过量通常高于92%。所报告的方法适用于合成大量对映纯的4-氨基醇喹啉衍生物。
  • [EN] 4-AMINOALCOHOLQUINOLINE DERIVATIVES, ENANTIOSELECTIVE SYNTHESIS METHODS AND THE USE THEREOF<br/>[FR] DÉRIVÉS DE 4-AMINO-ALCOOLQUINOLÉINE, PROCÉDÉS DE SYNTHÈSE ÉNANTIOSÉLECTIVE ET UTILISATION DE CEUX-CI
    申请人:UNIV PICARDIE
    公开号:WO2012107532A1
    公开(公告)日:2012-08-16
    The present invention is intended to provide new antimalarial compounds with a strong antimalarial activity as well as antibacterial activity with few neurological side effects and a new enantioselective pathway to mefloquine amino-analogs allowing the access of such compounds. The present invention relates to new 4 -aminoalcohol quinoline derivatives of formula (I), as well as the synthesis methods and the uses of such derivatives. In which Y is one selected from formulae (II) to (III). In which Z is selected from formulae (IV) to (VI), and wherein R1, R2, R3, R4, R5, R6, R7 and n are as defined in the claims.
    本发明旨在提供具有强抗疟活性和抗菌活性,且神经系统副作用少的新型抗疟疾化合物,以及一种新的对映选择性途径,允许访问这种化合物的甲氟喹胺类似物。本发明涉及公式(I)的新型4-氨基醇喹啉衍生物,以及这种衍生物的合成方法和用途,其中Y是从公式(II)到(III)中选择的一个,Z是从公式(IV)到(VI)中选择的一个,R1、R2、R3、R4、R5、R6、R7和n如权利要求所定义。
  • First enantioselective synthesis of 4-aminoalcohol quinoline derivatives through a regioselective SN2 epoxide opening mechanism
    作者:Alexia Jonet、Alexandra Dassonville-Klimpt、Sophie Da Nascimento、Jean-Michel Leger、Jean Guillon、Pascal Sonnet
    DOI:10.1016/j.tetasy.2011.01.003
    日期:2011.1
    Mefloquine derivatives, contrary to chloroquine derivatives have not been widely studied to date. Consequently, mefloquine and its derivatives still remain very attractive synthetic targets. Although mefloquine is usually used clinically as a racemic mixture, some studies have shown that its (+)-enantiomer is more potent than the (-)-enantiomer. Moreover, the (-)-enantiomer is responsible for side effects due to reaction with the central nervous system adenosine receptors, while the (+)-enantiomer does no bind at this binding site. Recently, different libraries of racemic 4-aminoalcohol quinolines showed interesting antimalarial activities. Herein, we describe an enantiopure synthetic and straightforward route to prepare pure enantiomer 4-aminoalcohol quinoline derivatives through a 4-oxirane key-intermediate. A regioselective S(N)2 ring opening of this epoxide, by diverse amines, allows us to obtain the corresponding (R) or (S) 4-aminoquinolines with good yields and enantiomeric excesses generally superior to 92%. The reported methodology appears suitable for the synthesis of a large number of pure enantiomer 4-aminoalcohol quinoline derivatives. (C) 2011 Elsevier Ltd. All rights reserved.
  • Meshram, H. M.; Chennakesava Reddy, B.; Aravind Kumar, D., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2012, vol. 51, # 9, p. 1411 - 1416,6
    作者:Meshram, H. M.、Chennakesava Reddy, B.、Aravind Kumar, D.、Kalyan, M.、Ramesh, P.、Kavitha, P.、Venkateswara Rao, J.
    DOI:——
    日期:——
  • Synthesis of Quinoline Analogs: Search for Antimalarial Agents
    作者:Konda Ramesh Babu、Begari Eeshwaraiah、Dachepally Aravind、Harshadas M. Meshram、Rallabaldi Madhusudan Raju、Apurba Bhattacharya、Rakeshwar Bandichhor
    DOI:10.1007/s00706-007-0772-5
    日期:2008.2
    Novel synthesis routes for the promising antimalarial agents 4(3-hydroxypyrrolidin-1-yl) and 4(3-hydroxypiperidine-1-yl)-2,8-bis(trifluoromethyl)quinoline have been developed.
    已开发出有前途的抗疟药4(3-羟基吡咯烷-1-基)和4(3-羟基哌啶-1-基)-2,8-双(三氟甲基)喹啉的新颖合成途径。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐